Influence of Platelet-specific Soluble Guanylyl Cyclase Deficiency on Atherosclerotic Plaque Formation

被引:0
|
作者
Stroth, Marlene
Bettaga, Noomen
Wobst, Jana
Werner, Julia
Zimmermann, Anna-Sophia
Friebe, Andreas
Sager, Hendrik B.
Schunkert, Heribert
Kessler, Thorsten
机构
关键词
D O I
10.1161/atvb.38.suppl_1.471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
471
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
    Mauersberger, Carina
    Sager, Hendrik B.
    Wobst, Jana
    Dang, Tan An
    Lambrecht, Laura
    Koplev, Simon
    Stroth, Marlene
    Bettaga, Noomen
    Schlossmann, Jens
    Wunder, Frank
    Friebe, Andreas
    Bjoerkegren, Johan L. M.
    Dietz, Lisa
    Maas, Sanne L.
    van der Vorst, Emiel P. C.
    Sandner, Peter
    Soehnlein, Oliver
    Schunkert, Heribert
    Kessler, Thorsten
    NATURE CARDIOVASCULAR RESEARCH, 2022, 1 (12): : 1174 - +
  • [2] Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
    Carina Mauersberger
    Hendrik B. Sager
    Jana Wobst
    Tan An Dang
    Laura Lambrecht
    Simon Koplev
    Marlène Stroth
    Noomen Bettaga
    Jens Schlossmann
    Frank Wunder
    Andreas Friebe
    Johan L. M. Björkegren
    Lisa Dietz
    Sanne L. Maas
    Emiel P. C. van der Vorst
    Peter Sandner
    Oliver Soehnlein
    Heribert Schunkert
    Thorsten Kessler
    Nature Cardiovascular Research, 2022, 1 : 1174 - 1186
  • [3] PLATELET SOLUBLE GUANYLYL CYCLASE DEFICIENCY PROMOTES ATHEROSCLEROSIS IN MICE
    Mauersberger, C. M.
    Sager, H. B.
    Wobst, J.
    Stroth, M.
    Friebe, A.
    Sandner, P.
    Soehnlein, O.
    Schunkert, H.
    Kessler, T.
    ATHEROSCLEROSIS, 2022, 355 : E50 - E50
  • [4] SOLUBLE GUANYLYL CYCLASE AND PLATELET-FUNCTION
    BUECHLER, WA
    IVANOVA, K
    WOLFRAM, G
    DRUMMER, C
    HEIM, JM
    GERZER, R
    PLATELET-DEPENDENT VASCULAR OCCLUSION, 1994, 714 : 151 - 157
  • [5] The effect of hypercholesterolemia on platelet soluble guanylyl cyclase
    Kottenberg-Assenmacher, E
    Weber, M
    Kojda, G
    VASCULAR PHARMACOLOGY, 2003, 40 (03) : 141 - 147
  • [6] CHARACTERIZATION OF SOLUBLE PLATELET GUANYLYL CYCLASE WITH PEPTIDE ANTIBODIES
    GUTHMANN, F
    MAYER, B
    KOESLING, D
    KUKOVETZ, WR
    BOHME, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 346 (05) : 537 - 541
  • [7] Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation
    Zhang, Guoying
    Xiang, Binggang
    Dong, Anping
    Skoda, Radek C.
    Daugherty, Alan
    Smyth, Susan S.
    Du, Xiaoping
    Li, Zhenyu
    BLOOD, 2011, 118 (13) : 3670 - 3679
  • [8] THE TRANS INFLUENCE OF NO IN SOLUBLE GUANYLYL CYCLASE - A MECHANISM FOR ACTIVATION
    REYNOLDS, MF
    GRAHAM, JP
    DIERKS, EA
    BURSTYN, JN
    BURSTEN, BE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 95 - INOR
  • [9] Biphasic Roles for the Soluble Guanylyl Cyclase (sGC) In Platelet Activation In Mice
    Zhang, Guoying
    Xiang, Binggang
    Skoda, Radek C.
    Smyth, Susan S.
    Du, Xiaoping
    Li, Zhenyu
    BLOOD, 2010, 116 (21) : 216 - 216
  • [10] Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
    Olesen, SP
    Drejer, J
    Axelsson, O
    Moldt, P
    Bang, L
    Nielsen-Kudsk, JE
    Busse, R
    Mülsch, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) : 299 - 309